The increasing incidence of infections by carbapenem-resistant enterobacteria (CRE), in particular carbapenem-resistant Klebsiella pneumoniae (CRKp), is a significant public health challenge worldwide.[1][1] The interim results of the last European survey on CRE (EuSCAPE project 2013) indicate that
No takes yet. Share an insight, caveat, or question.
Girmenia et al. (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: